sdz ens 163 has been researched along with scopolamine hydrobromide in 1 studies
| Studies (sdz ens 163) | Trials (sdz ens 163) | Recent Studies (post-2010) (sdz ens 163) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
|---|---|---|---|---|---|
| 6 | 1 | 0 | 7,548 | 563 | 1,401 |
| Protein | Taxonomy | sdz ens 163 (IC50) | scopolamine hydrobromide (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brass, EP; Cutler, NR; Jones, D; Moore, M; Polinsky, R; Sramek, JJ; Veroff, AE; Wardle, TS | 1 |
1 trial(s) available for sdz ens 163 and scopolamine hydrobromide
| Article | Year |
|---|---|
Effects of the cholinomimetic SDZ ENS-163 on scopolamine-induced cognitive impairment in humans.
Topics: Adult; Analysis of Variance; Cholinergic Agents; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Humans; Imidazoles; Male; Saliva; Scopolamine; Thiophenes | 1995 |